Ensuring the safety of medicinal products requires continuous monitoring throughout clinical development and after commercialization. Pharmacovigilance helps organizations identify, evaluate, document, and manage safety information while maintaining appropriate regulatory processes.
For companies conducting clinical trials or managing pharmaceutical products in Sweden, reliable Pharmacovigilance Services in Sweden can support safety monitoring across the product lifecycle.
CurexBio Research provides pharmacovigilance support covering ICSR management, medical review, safety reporting, signal detection, risk management, safety database management, literature monitoring, and regulatory support.
What Is Pharmacovigilance?
Pharmacovigilance refers to the science and activities involved in detecting, assessing, understanding, and preventing adverse effects or other medicine-related problems.
A structured pharmacovigilance system can include:
- Adverse event and serious adverse event management
- ICSR processing
- Medical review and causality assessment
- Safety reporting
- Signal detection
- Risk management
- Literature monitoring
- Safety database management
- Regulatory safety support
These activities contribute to ongoing evaluation of a medicinal product's safety profile.
Pharmacovigilance Services in Sweden
Pharmacovigilance requirements can extend from early clinical development through post-marketing surveillance. Sponsors may therefore need ongoing support for collecting safety information, processing cases, reviewing safety data, and preparing regulatory reports.
CurexBio provides pharmacovigilance services designed to support these activities through a coordinated safety management approach.
ICSR Management
Individual Case Safety Reports (ICSRs) are an important component of pharmacovigilance operations.
CurexBio's support can cover:
- Case intake and triage
- Initial case assessment
- Data entry
- Medical coding
- Case processing
- Quality control
- Follow-up information
- Safety database reconciliation
A structured case management process helps maintain consistency and accuracy when handling safety information.
Medical Review & Causality Assessment
Individual safety cases may require medical evaluation to understand the clinical significance of reported events.
Medical review activities can include:
- Review of patient and medical information
- Adverse event assessment
- Causality assessment
- Seriousness assessment
- Expectedness evaluation
- Clinical interpretation of safety cases
These assessments support appropriate case documentation and safety reporting.
Safety Reporting
Timely and accurate safety reporting is an important part of pharmacovigilance.
Depending on the product and reporting requirements, support may include:
- Expedited safety reports
- SUSAR-related activities
- DSUR preparation
- PSUR/PBRER support
- Periodic safety reporting
- Regulatory safety documentation
CurexBio supports both individual case processing and aggregate safety reporting activities.
Signal Detection & Safety Surveillance
Safety information needs to be evaluated continuously to identify potential emerging safety concerns.
Signal management can involve:
- Safety data review
- Signal detection
- Signal validation
- Trend analysis
- Medical assessment
- Safety surveillance
- Benefit-risk evaluation
A structured signal management process helps organizations assess whether new safety information requires further investigation.
Risk Management
Risk management focuses on identifying and evaluating known and potential risks associated with medicinal products.
Support may include:
- Risk identification
- Benefit-risk assessment
- Risk Management Plans
- Risk evaluation
- Risk minimization strategies
- Ongoing safety assessment
Risk management activities can be integrated with broader pharmacovigilance processes throughout the product lifecycle.
Safety Database Management
A reliable safety database is central to pharmacovigilance operations. It allows safety information to be recorded, tracked, reviewed, and retrieved for reporting and analysis.
Support may include:
- Safety database setup and maintenance
- Case data management
- Database quality checks
- Data reconciliation
- Safety data review
- System-related support
CurexBio also provides support involving established safety technology and validated processes.
Literature Monitoring
Scientific literature can provide additional information about adverse events and emerging safety concerns.
Literature monitoring may involve:
- Database and literature searches
- Identification of relevant publications
- Safety information review
- Case identification
- Medical assessment
- Documentation of findings
Regular literature surveillance can complement other sources of pharmacovigilance information.
Regulatory Pharmacovigilance Support
Pharmacovigilance activities must be aligned with applicable regulatory expectations. Sponsors may require support with safety documentation, reporting processes, and regulatory interactions.
Services may include:
- Regulatory safety reporting
- Safety documentation
- Regulatory submissions
- EudraVigilance-related support
- Compliance support
- Pharmacovigilance system documentation
Pharmacovigilance During Clinical Trials
Safety monitoring begins during clinical development, where investigators and sponsors collect safety information from participants throughout a study.
Clinical trial pharmacovigilance may involve:
- AE and SAE processing
- ICSR management
- Medical review
- Safety database management
- SUSAR-related activities
- Safety reconciliation
- Safety reporting
- Ongoing safety surveillance
Integrating pharmacovigilance with clinical trial operations helps maintain a structured approach to safety information throughout development.
Post-Marketing Pharmacovigilance
Safety monitoring continues after a medicinal product reaches the market. A larger and more diverse patient population can generate additional safety information that needs to be evaluated.
Post-marketing pharmacovigilance may include:
- ICSR processing
- Literature monitoring
- Signal detection
- Aggregate reporting
- Risk management
- Safety surveillance
- Benefit-risk assessment
Continuous post-marketing monitoring supports the ongoing evaluation of a product's safety profile.
PV Training, Audits & Inspection Readiness
A strong pharmacovigilance system also depends on trained personnel, documented procedures, quality oversight, and inspection preparedness.
CurexBio provides support in areas such as:
- Pharmacovigilance training
- PV system audits
- Internal audits
- Vendor and affiliate audits
- SOP development and review
- Mock inspections
- Inspection readiness
- Regulatory updates
These activities can help organizations maintain consistency across their pharmacovigilance processes.
Why Choose CurexBio?
CurexBio provides a broad pharmacovigilance service model covering the key activities required for ongoing drug safety management.
Its capabilities include:
ICSR Management → Medical Review → Safety Reporting → Signal Detection → Risk Management → Safety Database Management → Literature Monitoring → Regulatory Support
CurexBio also provides pharmacovigilance support across multiple countries, combining safety expertise, technology, and regulatory knowledge to support global safety operations.
Conclusion
Pharmacovigilance is an ongoing responsibility that extends from clinical trials through post-marketing surveillance. Effective safety management requires accurate case processing, medical assessment, continuous safety monitoring, regulatory reporting, and risk evaluation.
With comprehensive Pharmacovigilance Services in Sweden, CurexBio Research supports organizations with ICSR management, medical review, safety reporting, signal detection, risk management, literature monitoring, safety database management, and regulatory pharmacovigilance support.
Looking for Pharmacovigilance Services in Sweden? Contact CurexBio Research to discuss your drug safety requirements.
Comments